220 related articles for article (PubMed ID: 31397922)
21. Elevated vimentin expression in buccal mucosal fibroblasts by arecoline in vitro as a possible pathogenesis for oral submucous fibrosis.
Chang YC; Tsai CH; Tai KW; Yang SH; Chou MY; Lii CK
Oral Oncol; 2002 Jul; 38(5):425-30. PubMed ID: 12110335
[TBL] [Abstract][Full Text] [Related]
22. Curcumin relieves arecoline-induced oral submucous fibrosis via inhibiting the LTBP2/NF-κB axis.
Zhang L; Tan J; Liu Y; Luo M
Oral Dis; 2024 May; 30(4):2314-2324. PubMed ID: 37382472
[TBL] [Abstract][Full Text] [Related]
23. Identification of a BRAF/PA28γ/MEK1 signaling axis and its role in epithelial-mesenchymal transition in oral submucous fibrosis.
Xie C; Li Z; Hua Y; Sun S; Zhong L; Chen Q; Feng H; Ji N; Li T; Zhou X; Zeng X; Tang Z; Sun C; Li J; Chen Q
Cell Death Dis; 2022 Aug; 13(8):701. PubMed ID: 35961969
[TBL] [Abstract][Full Text] [Related]
24. The upregulation of insulin-like growth factor-1 in oral submucous fibrosis.
Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
Oral Oncol; 2005 Oct; 41(9):940-6. PubMed ID: 16054426
[TBL] [Abstract][Full Text] [Related]
25. Experimental study on TGF-β1-mediated CD147 expression in oral submucous fibrosis.
Wang W; Xiong H; Hu Z; Zhao R; Hu Y; Chen W; Han Y; Yang L; Hu X; Wang C; Mao T; Xia K; Su T
Oral Dis; 2018 Sep; 24(6):993-1000. PubMed ID: 29457855
[TBL] [Abstract][Full Text] [Related]
26. Arecoline stimulated early growth response-1 production in human buccal fibroblasts: suppression by epigallocatechin-3-gallate.
Hsieh YP; Chen HM; Chang JZ; Chiang CP; Deng YT; Kuo MY
Head Neck; 2015 Apr; 37(4):493-7. PubMed ID: 24436257
[TBL] [Abstract][Full Text] [Related]
27. Effects of arecoline, safrole, and nicotine on collagen phagocytosis by human buccal mucosal fibroblasts as a possible mechanism for oral submucous fibrosis in Taiwan.
Shieh DH; Chiang LC; Lee CH; Yang YH; Shieh TY
J Oral Pathol Med; 2004 Oct; 33(9):581-7. PubMed ID: 15357680
[TBL] [Abstract][Full Text] [Related]
28. Role of autophagy induced by arecoline in angiogenesis of oral submucous fibrosis.
Dai Z; Zhu B; Yu H; Jian X; Peng J; Fang C; Wu Y
Arch Oral Biol; 2019 Jun; 102():7-15. PubMed ID: 30951892
[TBL] [Abstract][Full Text] [Related]
29. Arecoline inhibits epithelial cell viability by upregulating the apoptosis pathway: implication for oral submucous fibrosis.
Li M; Gao F; Zhou ZS; Zhang HM; Zhang R; Wu YF; Bai MH; Li JJ; Lin SR; Peng JY
Oncol Rep; 2014 May; 31(5):2422-8. PubMed ID: 24647969
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin (1-7) inhibits arecoline-induced migration and collagen synthesis in human oral myofibroblasts via inhibiting NLRP3 inflammasome activation.
You Y; Huang Y; Wang D; Li Y; Wang G; Jin S; Zhu X; Wu B; Du X; Li X
J Cell Physiol; 2019 Apr; 234(4):4668-4680. PubMed ID: 30246378
[TBL] [Abstract][Full Text] [Related]
31. Tyrosine sulphation of CXCR4 induces the migration of fibroblast in OSF.
He C; Wang W; Wan W; Liang J; Hu J; Yuan Y; Jiang C; Li N
Oral Dis; 2023 May; 29(4):1782-1790. PubMed ID: 35150031
[TBL] [Abstract][Full Text] [Related]
32. Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma.
Li Z; Fu Y; Hu Y; Zhu Y; Hu L; Shi C; Zhang Y; Zhang J; Zhou S
BMC Oral Health; 2023 Mar; 23(1):171. PubMed ID: 36966276
[TBL] [Abstract][Full Text] [Related]
33. Oral submucous fibrosis stimulates invasion and epithelial-mesenchymal transition in oral squamous cell carcinoma by activating MMP-2 and IGF-IR.
Chen PN; Lin CW; Yang SF; Chang YC
J Cell Mol Med; 2021 Oct; 25(20):9814-9825. PubMed ID: 34528373
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-13 contributes to the occurrence of oral submucosal fibrosis.
Wang L; Tang Z; Huang J
J Cell Mol Med; 2023 Jul; 27(13):1797-1805. PubMed ID: 37337411
[TBL] [Abstract][Full Text] [Related]
35. Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis.
Chang YC; Yang SF; Tai KW; Chou MY; Hsieh YS
Oral Oncol; 2002 Feb; 38(2):195-200. PubMed ID: 11854068
[TBL] [Abstract][Full Text] [Related]
36. The up-regulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: a possible role in the pathogenesis of oral submucous fibrosis.
Tsai CH; Chou MY; Chang YC
J Oral Pathol Med; 2003 Mar; 32(3):146-53. PubMed ID: 12581384
[TBL] [Abstract][Full Text] [Related]
37. The Role of Increased Connective Tissue Growth Factor in the Pathogenesis of Oral Submucous Fibrosis and its Malignant Transformation-An Immunohistochemical Study.
Shah AM; Jain K; Desai RS; Bansal S; Shirsat P; Prasad P; Bodhankar K
Head Neck Pathol; 2021 Sep; 15(3):817-830. PubMed ID: 33544386
[TBL] [Abstract][Full Text] [Related]
38. Senescent epithelial cells remodel the microenvironment for the progression of oral submucous fibrosis through secreting TGF-β1.
Wang Z; Han Y; Peng Y; Shao S; Nie H; Xia K; Xiong H; Su T
PeerJ; 2023; 11():e15158. PubMed ID: 37096061
[TBL] [Abstract][Full Text] [Related]
39. Arecoline-stimulated connective tissue growth factor production in human buccal mucosal fibroblasts: Modulation by curcumin.
Deng YT; Chen HM; Cheng SJ; Chiang CP; Kuo MY
Oral Oncol; 2009 Sep; 45(9):e99-e105. PubMed ID: 19457704
[TBL] [Abstract][Full Text] [Related]
40. The upregulation of heat shock protein 47 expression in human buccal fibroblasts stimulated with arecoline.
Yang SF; Tsai CH; Chang YC
J Oral Pathol Med; 2008 Apr; 37(4):206-10. PubMed ID: 18221324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
